STOCK TITAN

CVD Equipment (CVV) posts Q2 profit on SDC sale amid sharp revenue drop

(Moderate)
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

CVD Equipment Corporation reported second-quarter 2026 results reflecting a major portfolio shift and weaker core operations. Revenue from continuing operations was $1.95 million, down 42.6% from the prior-year quarter, and the company recorded a net loss from continuing operations of $1.37 million. Including the divestiture of its SDC business, income from discontinued operations reached $13.94 million, driving net income to $12.57 million, or $1.81 per share. For the first half of 2026, revenue was $3.80 million versus $9.74 million in 2025, with a $3.10 million loss from continuing operations but $10.90 million net income after discontinued operations.

The April 2026 sale of SDC generated $17.40 million total consideration and a $13.50 million net gain, leaving CVD with $23.5 million in cash and no debt at June 30, 2026. Working capital was $25.8 million. Backlog declined to $3.9 million, and bookings for Q2 were about $1.2 million. The company expects existing cash, receivables, contract assets and backlog to cover its needs for at least 12 months, but highlights order volatility, customer concentration, and macro/geopolitical risks.

Positive

  • $13.5 million gain on the sale of the SDC division produced $12.6 million Q2 net income and $10.9 million net income for the first half of 2026.
  • Cash and cash equivalents increased to $23.5 million with no outstanding debt, and working capital rose to $25.8 million, strengthening liquidity.
  • Net cash provided by investing activities of $16.2 million (primarily SDC proceeds) plus net cash used in operations of only $1.3 million leaves the company well-funded for near-term needs.

Negative

  • Continuing operations remain weak, with Q2 2026 revenue down 42.6% to $1.95 million and first-half revenue down 61.0% to $3.80 million versus 2025.
  • Gross margin from continuing operations fell to 12.6% for the first half of 2026 (from 23.5%), and the operating loss widened to $3.35 million.
  • Order momentum is soft: Q2 bookings were about $1.2 million and backlog declined to $3.9 million, with one $0.8 million system order tied to a customer in Chapter 11.
  • Revenue concentration risk is elevated, with two customers representing 50.9% and 24.3% of Q2 revenue and two customers comprising over 80% of accounts receivable at June 30, 2026.

Filing Explained

A customer’s post-quarter Chapter 11 filing puts a $0.8 million order—and part of the $3.9 million backlog—into an unresolved status.

The filing puts the company’s $3.9 million June 30 backlog in an unresolved position for one $0.8 million system order: after quarter-end, that customer filed a prepackaged Chapter 11 proceeding, and the company says the purchase may not proceed as originally contemplated.

The backlog includes $2.7 million of remaining performance obligations on contracts in progress and approximately $1.1 million of other customer orders. Separately, the company reports $2.7 million of unrecognized contract revenue that it expects to substantially recognize within the next 12 months under its over-time revenue method.

Customer concentration makes the order issue more specific: one aerospace customer represented 36.0% of backlog at June 30, while two customers represented 53.2% and 27.3% of accounts receivable.

The stated resolution path is continued monitoring of the customer’s proceedings and evaluation of any effect on backlog, financial position, results of operations, and cash flows.

Q2 2026 Revenue (continuing ops) $1,953,000 Revenue for the three months ended June 30, 2026 from continuing operations
Q2 2026 Net Income $12,565,000 Net income including discontinued operations for the three months ended June 30, 2026
Gain on SDC Disposition $13,500,000 Net gain on disposition of SDC, including income tax expense, in first half 2026
Cash and Cash Equivalents $23,483,000 Cash and cash equivalents balance at June 30, 2026
Loss from Continuing Ops H1 2026 $3,097,000 Net loss from continuing operations for the six months ended June 30, 2026
Backlog $3,900,000 Approximate order backlog at June 30, 2026
Working Capital $25,800,000 Aggregate working capital at June 30, 2026
Unrecognized Contract Revenue $2,700,000 Unrecognized contract revenue expected to be substantially recognized within 12 months at June 30, 2026
discontinued operations financial
"the financial results of the SDC business division are reflected ... as discontinued operations"
Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.
contract assets financial
"Contract assets include unbilled amounts typically resulting from system sales under contracts"
Contract assets are amounts a company has earned by doing work or delivering goods under a customer agreement but has not yet billed or collected because certain contract conditions remain. Think of it as completed work sitting in a company’s toolbox waiting for an invoice trigger. For investors, growing contract assets signal future cash and revenue potential but also raise questions about timing, cash collection risk and the real strength of reported sales.
backlog financial
"Backlog declined from $4.6 million at March 31, 2026 to $3.9 million at June 30, 2026"
A backlog is the amount of work or orders that a company has received but hasn't completed yet. It’s like a restaurant with many dishes to serve; the backlog shows how many orders are still waiting to be finished. It matters because a large backlog can indicate strong demand or potential delays in delivering products or services.
valuation allowance financial
"the Company has provided a full valuation allowance against its net deferred tax asset"
A valuation allowance is a reserve set aside to reduce the value of certain assets on a company's financial records when there is uncertainty about whether they will generate the expected benefits. It acts like a caution sign, indicating that some assets might not be fully recoverable or worth their recorded amount. This matters to investors because it provides a more realistic picture of a company's financial health and potential risks.
stock-based compensation financial
"The Company recorded stock-based compensation for the three and six months ended June 30, 2026"
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
Revenue (Q2 2026, continuing ops) $1,953,000 Decreased 42.6% from $3,404,000 in Q2 2025
Revenue (H1 2026, continuing ops) $3,798,000 Decreased 61.0% from $9,737,000 in H1 2025
Net income (Q2 2026, total) $12,565,000 Improved from net loss of $1,061,000 in Q2 2025, driven by SDC gain
Net income (H1 2026, total) $10,902,000 Improved from net loss of $701,000 in H1 2025
Loss from continuing ops (H1 2026) $3,097,000 Worsened from $1,521,000 loss in H1 2025
Cash and cash equivalents $23,483,000 Increased from $8,734,000 at December 31, 2025

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How did CVD Equipment (CVV) perform financially in Q2 2026?

CVD reported Q2 2026 revenue of $1.95 million from continuing operations and a net loss from continuing operations of $1.37 million. Including discontinued operations from the SDC sale, net income was $12.57 million, or $1.81 per share.

What impact did the SDC division sale have on CVV’s 2026 results?

The SDC sale generated $17.4 million in consideration and a $13.5 million net gain. Income from discontinued operations was $13.94 million in Q2 and $13.999 million for the first half, transforming overall results to a $10.9 million first-half net profit.

What is CVD Equipment’s cash and debt position as of June 30, 2026?

As of June 30, 2026, CVD held $23.5 million in cash and cash equivalents and had no outstanding debt. Working capital totaled $25.8 million, and management believes liquidity is sufficient for at least the next 12 months.

What customer concentration risks does CVD Equipment (CVV) face?

CVD disclosed that during Q2 2026, two customers accounted for 50.9% and 24.3% of revenue. At June 30, 2026, two customers represented 53.2% and 27.3% of accounts receivable, highlighting significant dependence on a few customers.

How did CVV’s first-half 2026 revenue and margins compare to 2025?

For the six months ended June 30, 2026, revenue from continuing operations was $3.80 million, down from $9.74 million in 2025. Gross profit decreased to $0.48 million and gross margin to 12.6%, versus $2.29 million and 23.5% a year earlier.

What strategic changes is CVD Equipment (CVV) pursuing after the SDC sale?

CVD is executing a transformation strategy that includes outsourcing certain fabrication to lower fixed costs and evaluating strategic alternatives for remaining product lines, including potential sales, divestitures, or acquisitions, while focusing on aerospace, semiconductor, and industrial end markets.
false Q2 --12-31 0000766792 0000766792 2026-01-01 2026-06-30 0000766792 2026-08-11 0000766792 2026-06-30 0000766792 2025-12-31 0000766792 2026-04-01 2026-06-30 0000766792 2025-04-01 2025-06-30 0000766792 2025-01-01 2025-06-30 0000766792 us-gaap:CommonStockMember 2026-03-31 0000766792 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000766792 us-gaap:RetainedEarningsMember 2026-03-31 0000766792 2026-03-31 0000766792 us-gaap:CommonStockMember 2025-03-31 0000766792 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000766792 us-gaap:RetainedEarningsMember 2025-03-31 0000766792 2025-03-31 0000766792 us-gaap:CommonStockMember 2025-12-31 0000766792 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000766792 us-gaap:RetainedEarningsMember 2025-12-31 0000766792 us-gaap:CommonStockMember 2024-12-31 0000766792 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000766792 us-gaap:RetainedEarningsMember 2024-12-31 0000766792 2024-12-31 0000766792 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000766792 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000766792 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000766792 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000766792 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000766792 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000766792 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0000766792 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0000766792 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0000766792 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0000766792 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0000766792 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0000766792 us-gaap:CommonStockMember 2026-06-30 0000766792 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000766792 us-gaap:RetainedEarningsMember 2026-06-30 0000766792 us-gaap:CommonStockMember 2025-06-30 0000766792 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000766792 us-gaap:RetainedEarningsMember 2025-06-30 0000766792 2025-06-30 0000766792 CVV:AssetPurchaseAgreementMember 2026-03-23 0000766792 CVV:AssetPurchaseAgreementMember 2026-03-23 2026-03-23 0000766792 CVV:LeaseAgreementMember 2026-03-23 2026-03-23 0000766792 us-gaap:SegmentDiscontinuedOperationsMember 2025-12-31 0000766792 us-gaap:SegmentDiscontinuedOperationsMember 2026-04-01 2026-06-30 0000766792 us-gaap:SegmentDiscontinuedOperationsMember 2025-04-01 2025-06-30 0000766792 us-gaap:SegmentDiscontinuedOperationsMember 2026-01-01 2026-06-30 0000766792 us-gaap:SegmentDiscontinuedOperationsMember 2025-01-01 2025-06-30 0000766792 us-gaap:USTreasuryBillSecuritiesMember 2026-06-30 0000766792 us-gaap:USTreasuryBillSecuritiesMember 2025-12-31 0000766792 us-gaap:AccountsReceivableMember CVV:CustomerOneMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-06-30 0000766792 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerTwoMember 2026-01-01 2026-06-30 0000766792 us-gaap:AccountsReceivableMember CVV:CustomerOneMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0000766792 us-gaap:AccountsReceivableMember CVV:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerOneMember 2026-04-01 2026-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerTwoMember 2026-04-01 2026-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerOneMember 2026-01-01 2026-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerTwoMember 2026-01-01 2026-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerThreeMember 2026-01-01 2026-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerOneMember 2025-04-01 2025-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerTwoMember 2025-04-01 2025-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerThreeMember 2025-04-01 2025-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerOneMember 2025-01-01 2025-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerTwoMember 2025-01-01 2025-06-30 0000766792 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CVV:CustomerThreeMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:EnergyMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:EnergyMember 2026-04-01 2026-06-30 0000766792 CVV:EnergyMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:AerospaceMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:AerospaceMember 2026-04-01 2026-06-30 0000766792 CVV:AerospaceMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:IndustrialMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:IndustrialMember 2026-04-01 2026-06-30 0000766792 CVV:IndustrialMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:ResearchOneMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:ResearchOneMember 2026-04-01 2026-06-30 0000766792 CVV:ResearchOneMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember 2026-04-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:EnergyMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:EnergyMember 2025-04-01 2025-06-30 0000766792 CVV:EnergyMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:AerospaceMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:AerospaceMember 2025-04-01 2025-06-30 0000766792 CVV:AerospaceMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:IndustrialMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:IndustrialMember 2025-04-01 2025-06-30 0000766792 CVV:IndustrialMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:ResearchOneMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:ResearchOneMember 2025-04-01 2025-06-30 0000766792 CVV:ResearchOneMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember 2025-04-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:EnergyMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:EnergyMember 2026-01-01 2026-06-30 0000766792 CVV:EnergyMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:AerospaceMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:AerospaceMember 2026-01-01 2026-06-30 0000766792 CVV:AerospaceMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:IndustrialMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:IndustrialMember 2026-01-01 2026-06-30 0000766792 CVV:IndustrialMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:ResearchOneMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:ResearchOneMember 2026-01-01 2026-06-30 0000766792 CVV:ResearchOneMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:EnergyMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:EnergyMember 2025-01-01 2025-06-30 0000766792 CVV:EnergyMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:AerospaceMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:AerospaceMember 2025-01-01 2025-06-30 0000766792 CVV:AerospaceMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:IndustrialMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:IndustrialMember 2025-01-01 2025-06-30 0000766792 CVV:IndustrialMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember CVV:ResearchOneMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember CVV:ResearchOneMember 2025-01-01 2025-06-30 0000766792 CVV:ResearchOneMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredOverTimeMember 2025-01-01 2025-06-30 0000766792 us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-06-30 0000766792 2022-09-30 0000766792 CVV:LoanAgreementToFundMachineryAcquisitionMember 2022-09-01 2022-09-30 0000766792 CVV:CostOfRevenuesMember 2026-04-01 2026-06-30 0000766792 CVV:CostOfRevenuesMember 2025-04-01 2025-06-30 0000766792 CVV:CostOfRevenuesMember 2026-01-01 2026-06-30 0000766792 CVV:CostOfRevenuesMember 2025-01-01 2025-06-30 0000766792 CVV:ResearchAndDevelopmentExpensesMember 2026-04-01 2026-06-30 0000766792 CVV:ResearchAndDevelopmentExpensesMember 2025-04-01 2025-06-30 0000766792 CVV:ResearchAndDevelopmentExpensesMember 2026-01-01 2026-06-30 0000766792 CVV:ResearchAndDevelopmentExpensesMember 2025-01-01 2025-06-30 0000766792 CVV:SellingExpenseMember 2026-04-01 2026-06-30 0000766792 CVV:SellingExpenseMember 2025-04-01 2025-06-30 0000766792 CVV:SellingExpenseMember 2026-01-01 2026-06-30 0000766792 CVV:SellingExpenseMember 2025-01-01 2025-06-30 0000766792 CVV:GeneralAndAdministrativeExpensesMember 2026-04-01 2026-06-30 0000766792 CVV:GeneralAndAdministrativeExpensesMember 2025-04-01 2025-06-30 0000766792 CVV:GeneralAndAdministrativeExpensesMember 2026-01-01 2026-06-30 0000766792 CVV:GeneralAndAdministrativeExpensesMember 2025-01-01 2025-06-30 0000766792 us-gaap:RestrictedStockMember srt:DirectorMember 2026-04-01 2026-06-30 0000766792 us-gaap:RestrictedStockMember srt:DirectorMember 2025-04-01 2025-06-30 0000766792 us-gaap:RestrictedStockMember srt:DirectorMember 2026-01-01 2026-06-30 0000766792 us-gaap:RestrictedStockMember srt:DirectorMember 2025-01-01 2025-06-30 0000766792 CVV:DirectorsMember 2026-06-30 0000766792 us-gaap:EmployeeStockOptionMember 2026-06-30 0000766792 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-06-30 0000766792 CVV:ExercisePriceRangeOneMember 2026-01-01 2026-06-30 0000766792 CVV:ExercisePriceRangeOneMember 2026-06-30 0000766792 CVV:ExercisePriceRangeTwoMember 2026-01-01 2026-06-30 0000766792 CVV:ExercisePriceRangeTwoMember 2026-06-30 0000766792 CVV:ExercisePriceRangeThreeMember 2026-01-01 2026-06-30 0000766792 CVV:ExercisePriceRangeThreeMember 2026-06-30 0000766792 CVV:ExercisePriceRangeFourMember 2026-01-01 2026-06-30 0000766792 CVV:ExercisePriceRangeFourMember 2026-06-30 0000766792 srt:AmericasMember 2026-04-01 2026-06-30 0000766792 srt:AmericasMember 2025-04-01 2025-06-30 0000766792 srt:NorthAmericaMember 2026-04-01 2026-06-30 0000766792 srt:NorthAmericaMember 2025-04-01 2025-06-30 0000766792 us-gaap:EMEAMember 2026-04-01 2026-06-30 0000766792 us-gaap:EMEAMember 2025-04-01 2025-06-30 0000766792 srt:AsiaPacificMember 2026-04-01 2026-06-30 0000766792 srt:AsiaPacificMember 2025-04-01 2025-06-30 0000766792 srt:AmericasMember 2026-01-01 2026-06-30 0000766792 srt:AmericasMember 2025-01-01 2025-06-30 0000766792 srt:NorthAmericaMember 2026-01-01 2026-06-30 0000766792 srt:NorthAmericaMember 2025-01-01 2025-06-30 0000766792 us-gaap:EMEAMember 2026-01-01 2026-06-30 0000766792 us-gaap:EMEAMember 2025-01-01 2025-06-30 0000766792 srt:AsiaPacificMember 2026-01-01 2026-06-30 0000766792 srt:AsiaPacificMember 2025-01-01 2025-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CVV:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended June 30, 2026

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from ____ to _____

 

Commission file number: 1-16525

 

CVD EQUIPMENT CORPORATION

(Name of Registrant in Its Charter)

 

New York   11-2621692
State or Other Jurisdiction of
Incorporation or Organization)
 

(I.R.S. Employer

Identification No.)

 

355 South Technology Drive Central Islip, New York 11722

(Address of principal executive offices)

 

(631) 981-7081
(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   CVV   NASDAQ Capital Market

 

Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer ☐ Accelerated filer ☐  
Non-accelerated filer Smaller reporting company Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 6,951,203 shares of Common Stock, $0.01 par value at August 11, 2026.

 

 

 

 

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

 

Index

 

Part I - Financial Information  
       
  Item 1 – Condensed Consolidated Financial Statements (Unaudited)  
       
    Condensed Consolidated Balance Sheets at June 30, 2026 and December 31, 2025 3
       
    Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026 and 2025 4
       
    Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2026 and 2025 5
       
    Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2026 and 2025 6
       
    Notes to Condensed Consolidated Financial Statements 7
       
  Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
       
  Item 3 – Quantitative and Qualitative Disclosures About Market Risk 26
       
  Item 4 – Controls and Procedures 26
       
Part II - Other Information  
       
  Item 1 – Legal Proceedings 27
       
  Item 1A-Risk Factors 27
       
  Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds 27
       
  Item 3 – Defaults Upon Senior Securities 27
       
  Item 4 – Mine Safety Disclosures 27
       
  Item 5 – Other Information 27
       
  Item 6 – Exhibits 27
       
Signatures 28

 

2

 

 

PART 1 – FINANCIAL INFORMATION

Item 1 – Financial Statements

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except share amounts)

(Unaudited)

 

   June 30, 2026   December 31, 2025 
ASSETS          
Current assets          
Cash and cash equivalents  $23,483   $8,734 
Accounts receivable, net of allowance for credit losses   1,771    1,293 
Contract assets   1,397    2,853 
Inventories   247    285 
Amount held in escrow   900    - 
Current assets of discontinued operations   -    2,852 
Assets held for sale   -    510 
Other current assets   350    357 
Total current assets   28,148    16,884 
           
Property, plant and equipment, net   10,276    10,529 
Noncurrent assets of discontinued operations   -    46 
Other assets   99    50 
Total assets  $38,523   $27,509 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accounts payable  $155   $250 
Accrued expenses   1,060    849 
Income taxes payable   688    - 
Contract liabilities   541    560 
Current maturities of long-term debt   -    181 
Current liabilities of discontinued operations   -    944 
Total current liabilities   2,444    2,784 
           
Security deposit   30    - 
Total liabilities   2,474    2,784 
           
Contingencies – Note 12   -    - 
           
Stockholders’ equity:          
Common stock - $0.01 par value – authorized 20,000,000 shares; issued and outstanding 6,946,703 and 6,937,338 at June 30, 2026 and December 31, 2025, respectively   69    69 
Additional paid-in capital   31,121    30,699 
Retained earnings (accumulated deficit)   4,859    (6,043)
Total stockholders’ equity   36,049    24,725 
           
Total liabilities and stockholders’ equity  $38,523   $27,509 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

3

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share and share amounts)

(Unaudited)

 

   2026   2025   2026   2025 
   Three months ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Revenue  $1,953   $3,404   $3,798   $9,737 
Cost of revenue   1,624    2,923    3,321    7,451 
                     
Gross profit   329    481    477    2,286 
                     
Operating expenses:                    
Research and development   685    639    1,413    1,373 
Selling   232    282    472    649 
General and administrative   971    931    1,992    1,954 
Gain on sale of equipment   -    -    (46)   - 
                     
Total operating expenses   1,888    1,852    3,831    3,976 
                     
Operating loss from continuing operations   (1,559)   (1,371)   (3,354)   (1,690)
                     
Other income (expense):                    
Interest income   190    82    261    192 
Interest expense   -    (3)   (1)   (7)
Rental income, net of expenses   (3)   -    (3)   - 
Total other income, net   187    79    257    185 
                     
Loss from continuing operations before
income taxes
   (1,372)   (1,292)   (3,097)   (1,505)
                     
Income tax expense   -    -    -    16 
                     
Net loss from continuing operations   (1,372)   (1,292)   (3,097)   (1,521)
Income from discontinued operations, net of income taxes (Note 2)   13,937    231    13,999    820 
                     
Net income (loss)  $12,565   $(1,061)  $10,902   $(701)
                     
Net income (loss) per share of common stock – basic and diluted                    
Loss from continuing operations  $(0.20)  $(0.19)  $(0.45)  $(0.22)
Income from discontinued operations  $2.01   $0.03   $2.02   $0.12 
Net income (loss)  $1.81   $(0.15)  $1.58   $(0.10)
Weighted-average number of common shares outstanding - basic and diluted   6,927,388    6,867,868    6,918,614    6,860,846 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

4

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(in thousands, except share amounts)

(Unaudited)

 

Three months ended June 30, 2026 and 2025

 

   Shares   Par Value   Capital   Deficit)   Total 
       Additional   Retained Earnings     
   Common stock   Paid-in   (Accumulated     
   Shares   Par Value   Capital   Deficit)   Total 
                     
Balance at April 1, 2026   6,937,338   $    69   $30,919   $    (7,706)  $23,282 
Net income   -    -    -    12,565    12,565 
Stock-based compensation   9,365    -    202    -    202 
Balance at June 30, 2026   6,946,703   $69   $31,121   $4,859   $36,049 
                          
Balance at April 1, 2025   6,881,838   $69   $30,021   $(4,098)  $25,992 
Net loss   -    -    -    (1,061)   (1,061)
Stock-based compensation   -    -    250    -    250 
Balance at June 30, 2025   6,881,838   $69   $30,271   $(5,159)  $25,181 

 

Six months ended June 30, 2026 and 2025

 

       Additional   Retained Earnings     
   Common stock   Paid-in   (Accumulated     
   Shares   Par Value   Capital   Deficit)   Total 
                     
Balance at January 1, 2026   6,937,338   $    69   $30,699   $     (6,043)  $24,725 
Net income   -    -    -    10,902    10,902 
Stock-based compensation   9,365    -    422    -    422 
Balance at June 30, 2026   6,946,703   $69   $31,121   $4,859   $36,049 
                          
Balance at January 1, 2025   6,881,838   $69   $29,757   $(4,458)  $25,368 
                          
Net loss   -    -    -    (701)   (701)
Stock-based compensation   -    -    514    -    514 
Balance at June 30, 2025   6,881,838   $69   $30,271   $(5,159)  $25,181 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

5

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(in thousands)

(Unaudited)

 

   2026   2025 
   Six months ended 
   June 30, 
   2026   2025 
Cash flows from operating activities:          
Net income (loss)  $10,902   $(701)
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Stock-based compensation   422    514 
Depreciation and amortization   268    354 
Gain on disposition of SDC, net of income taxes   (13,500)   - 
Gain on sale of equipment   (46)   - 
Provision for bad debts   14    - 
Changes in assets and liabilities, net of the effects of disposition:          
Accounts receivable   (886)   (2,844)
Contract assets   1,651    (1,542)
Inventories   376    (213)
Other assets   (15)   511 
Accounts payable   (297)   260 
Accrued expenses   (144)   (653)
Contract liabilities   (52)   (1,118)
Security deposit   30    - 
Net cash used in operating activities   (1,277)   (5,432)
           
Cash flows from investing activities:          
Proceeds from disposition of SDC   15,715    - 
Proceeds from assets held for sale and sale of equipment   556    - 
Purchases of property and equipment   (14)   (49)
Investment in captive insurance company   (50)   (51)
Net cash provided by (used in) investing activities   16,207    (100)
           
Cash flows from financing activities          
Payments of long-term debt   (181)   (43)
Net cash used in financing activities   (181)   (43)
           
Net increase (decrease) in cash and cash equivalents   14,749    (5,575)
           
Cash and cash equivalents at beginning of period   8,734    12,598 
           
Cash and cash equivalents at end of period  $23,483   $7,023 
           
Supplemental disclosure of cash flow information:          
           
Income taxes paid  $3   $16 
Interest paid  $3   $7 
Non-cash activity – amount held in escrow  $900   $- 
Non-cash activity – accrued income taxes on gain on sale of SDC  $710   $

-

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

6

 

 

NOTE 1: BASIS OF PRESENTATION

 

The accompanying unaudited condensed consolidated financial statements for CVD Equipment Corporation and Subsidiaries (collectively “the Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. They do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary in order to make the interim financials not misleading have been included and all such adjustments are of a normal recurring nature. The operating results for the three and six months ended June 30, 2026 are not necessarily indicative of the results that can be expected for the year ending December 31, 2026.

 

The condensed consolidated balance sheet as of December 31, 2025 has been derived from the audited consolidated financial statements at such date, as filed on Form 10-K with the SEC on March 30, 2026, but does not contain all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with that report.

 

All material intercompany balances and transactions have been eliminated in consolidation.

 

On March 23, 2026, the Company entered into an agreement to sell its SDC business division to a third party. The sale was completed on April 1, 2026. Accordingly, the financial results of the SDC business division are reflected in the consolidated condensed financial statements as discontinued operations for all periods presented.

 

Unless otherwise specified, disclosures in these condensed consolidated financial statements reflect continuing operations only. Prior period financial information related to discontinued operations has been reclassified and separately presented in the consolidated financial statements and accompanying notes to conform to the current period presentation. See Note 2 for further information regarding our discontinued operations.

 

Reclassifications

 

Certain reclassifications have been made to the prior period condensed consolidated financial statements to conform to the current period presentation. These reclassifications had no effect on net loss.

 

Liquidity

 

At June 30, 2026, the Company had $23.5 million in cash and cash equivalents. The Company anticipates that the existing cash and cash equivalents balance together with collections of existing accounts receivable and contract assets, and revenue from its existing backlog of systems as of this filing date, will be adequate to meet its working capital and capital equipment requirements, and its anticipated cash needs over the next 12 months from the date of issuance of these condensed consolidated financial statements.

 

NOTE 2: DISCONTINUED OPERATIONS

 

On March 23, 2026, the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with a buyer to sell its SDC business division. On April 1, 2026, the Company completed the transaction whereby substantially all the assets related to SDC were sold.

 

7

 

 

NOTE 2: DISCONTINUED OPERATIONS (continued)

 

The aggregate consideration paid to the Company in connection with the transaction was $17.4 million. At closing, $0.9 million of the purchase price was placed in escrow to secure post-closing adjustments and indemnification obligations in accordance with the Asset Purchase Agreement. The Asset Purchase Agreement contains customary representations, warranties, covenants and indemnification provisions. The net cash proceeds from the sale of SDC received by the Company in April 2026, after payment of transaction costs and employee related liabilities, were $15.7 million. The Company expects to pay approximately $0.7 million in estimated income taxes related to the gain on the sale of SDC in the third quarter of 2026. The net gain on the sale of SDC, including related income tax expense, was $13.5 million.

 

The Company retained ownership of its Saugerties, New York facility and entered into a lease agreement with the buyer of SDC, pursuant to which the buyer will lease such facility for an initial term of two years following the closing for an initial annual rent of $0.2 million, subject to customary adjustments.

 

The transaction represents a single disposal plan that constitutes a strategic shift expected to have a material effect on our operations and financial results. Accordingly, the financial results of SDC are reflected in the condensed consolidated financial statements as discontinued operations for all periods presented.

 

The following table represents the gain on the disposition of SDC, net of income taxes, for the six months ended June 30, 2026 (in thousands):

 

      
Sales proceeds received  $16,499 
Amount held in escrow   900 
Total sales price   17,399 
Less:     
Net assets transferred to buyer   (2,405)
Transaction expenses   (784)
Income tax expense   (710)
Gain on disposition of SDC, net of income taxes  $13,500 

 

The following table represents the amounts of assets and liabilities of the discontinued operations of SDC as of December 31, 2025 (in thousands):

 

   December 31,
2025
 
Assets:     
Accounts receivable, net of allowance for credit losses  $1,021 
Contract assets   538 
Inventories   1,284 
Other current assets   9 
Equipment, net   44 
Other noncurrent assets   2 
Total assets  $2,898 
      
Liabilities:    
Accounts payable  $392 
Accrued expenses   339 
Contract liabilities   213 
Total liabilities  $944 

 

8

 

 

NOTE 2: DISCONTINUED OPERATIONS (continued)

 

The following table represents statements of operations information for the discontinued operations of SDC (in thousands):

 

   2026   2025   2026   2025 
   Three months ended June 30,   Six months ended June 30, 
   2026   2025   2026   2025 
                 
Revenue  $-   $1,707   $2,364   $3,690 
Cost of revenue   -    1,115    1,524    2,207 
Gross profit   -    592    840    1,483 
                     
Operating expenses:                    
Research and development   -    47    53    94 
Selling   -    67    62    120 
General and administrative   -    247    226    449 
Total operating expenses   -    361    341    663 
                     
Income from discontinued operations   -    231    499    820 
                     
Gain on disposition of SDC, net of income taxes   13,937    -    13,500    - 
                     
Income from discontinued operations, net of income taxes  $13,937   $231   $13,999   $820 

 

The significant components included in the accompanying condensed consolidated statements of cash flow for the discontinued operations of SDC are as follows (in thousands):

 

   2026   2025 
   Six months
ended June 30,
 
   2026   2025 
         
Net cash provided by operating activities  $60   $1,113 
Net cash provided by (used in) investing activities   15,715    (5)
Net cash provided by financing activities   -    - 

 

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

In accordance with FASB ASC 606 - Revenue from Contracts with Customers (“ASC 606”), the Company records revenue in an amount that reflects the consideration to which the Company expects to be entitled in exchange for goods or services promised to its customers. Under ASC 606, the Company follows a five-step model to: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price for the contract; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue using one of the following two methods:

 

9

 

 

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Over time

 

The Company designs, manufactures and sells custom chemical vapor deposition equipment through contractual agreements. These system sales require the Company to deliver functioning equipment that is generally completed within two to eighteen months from commencement of order acceptance. For systems sales that meet the criteria to recognize revenue over time, the Company recognizes revenue over time by using an input method based on costs incurred as it depicts the Company’s progress toward satisfaction of the performance obligation. For system sales that do not meet the criteria to recognize revenue over time based on the contract provisions, the Company recognizes revenue based on point in time.

 

Under the over time method, revenue arising from fixed price contracts is recognized as work is performed based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligations. Incurred costs include all direct material and labor costs and those indirect costs related to contract performance, such as supplies, tools, repairs and depreciation costs. Contract material costs are included in incurred costs when the project materials have been purchased or moved to work in process, and installed, as required by the project’s engineering design. Cost based input methods of revenue recognition require the Company to make estimates of costs to complete the projects. In making such estimates, significant judgment is required to evaluate assumptions related to the costs to complete the projects, including materials, labor and other system costs. If the estimated total costs on any contract are greater than the net contract revenues, the Company recognizes the entire estimated loss in the period the loss becomes known and can be reasonably estimated. There were no impairment losses recognized on contract assets during the three and six months ended June 30, 2026 and 2025.

 

The timing of revenue recognition, billings and collections results in accounts receivables, unbilled receivables or contract assets and contract liabilities on our condensed consolidated balance sheet. Under typical payment terms for our contracts accounted for over time, amounts are billed as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals or upon achievement of contractual milestones.

 

Under ASC 606, payments received from customers in excess of revenue recognized to date results in a contract liability. These contract liabilities are not considered to represent a significant financing component of the contract because we believe these cash advances and deposits are generally used to meet working capital demands which can be higher in the earlier stages of a contract. Also, advanced payments and deposits provide us with some measure of assurance that the customer will perform on its obligations under the contract.

 

Contract assets include unbilled amounts typically resulting from system sales under contracts and represent revenue recognized that exceeds the amount billed to the customer.

 

Contract liabilities include advance payments and billings in excess of revenue recognized. The Company typically receives down payments upon receipt of orders and progress payments as the system is manufactured.

 

Contract assets and contract liabilities are classified as current as these contracts in progress are expected to be substantially completed within the next twelve months.

 

Point in time

 

For non-system sales of products and services, revenue is recognized at the point in time when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606, “Revenue from Contracts with Customers”.

 

10

 

 

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

For any system equipment sales where the equipment would have an alternative use or where the contract provisions of the contract preclude the use of over time revenue recognition, revenue is recognized at the point in time when control of the equipment is transferred to the customer. For the three and six months ended June 30, 2026 and 2025, all system equipment sales were recorded over time by using an input method except for one contract that was entered into during 2024 and was not recognized as revenue using over time revenue recognition until July 2025 when a contract modification was entered into with the customer to change certain contract provisions.

 

Inventories

 

Inventories (raw materials, work-in-process and finished goods) are valued at the lower of cost (determined on the first-in, first-out method) or net realizable value. Work-in-process and finished goods inventory reflect all accumulated production costs, which are comprised of direct production costs and overhead, and is reduced by amounts recorded in cost of sales as the related revenue is recognized. Indirect costs relating to long-term contracts, which include expenses such as general and administrative, are charged to expense as incurred and are not included in our cost of sales or work-in-process and finished goods inventory.

 

Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made.

 

Product Warranty

 

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance or fifteen months from the date of shipment by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of revenue” in the condensed consolidated statements of operations. The estimated warranty cost is based on the Company’s historical cost. The Company updates its warranty estimates based on actual costs incurred.

 

Assets Held for Sale and Discontinued Operations

 

Assets and related liabilities of a qualifying business are classified as held for sale when the following conditions are met: (i) management has committed to a plan to sell the net assets, (ii) the net assets are available for immediate sale, (iii) there is an active program to locate a buyer, (iv) the sale and transfer of the net assets is probable within one year, (v) the net assets are being actively marketed for sale at a price that is reasonable in relation to the current fair value, and (vi) it is unlikely that significant changes will be made to the plan to sell the net assets. Assets and related liabilities which have been classified as held for sale are excluded from the net assets and liabilities of continuing operations in the period in which the held for sale criteria was met. A component of a business is classified as a discontinued operation when its disposal represents a strategic shift that has or will have a major effect on our operations and financial results. The results of discontinued operations are reported in income/loss from discontinued operations, net of tax on the consolidated statements of operations for all current and prior periods presented. The results of discontinued operations include direct costs attributable to the divested business and any gain or loss recognized in connection with the sale, or adjustment of the carrying amount to fair value less cost to sell while being held for sale, and excludes any indirect cost allocation associated with any shared-service or corporate functions not solely dedicated to the divested business. Adjustments to discontinued operations subsequent to the completion of a transaction or disposition are generally attributable to contingencies and indemnifications directly related to the disposal transaction, operations of the discontinued operations, or settlement of obligations directly related to the disposal.

 

11

 

 

NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Assets and liabilities of discontinued operations, including those that meet the held-for-sale criteria, are presented separately in the consolidated balance sheets. Upon classification as held for sale, assets are measured at the lower of carrying amount or fair value less cost to sell, and depreciation and amortization cease. Any impairment losses or subsequent measurement adjustments are recognized in the results of discontinued operations in the period in which they are identified. Cash flows attributable to discontinued operations are presented separately in the consolidated statements of cash flows, or otherwise disclosed, for all periods presented.

 

Recent Accounting Standards

 

In November 2024, the FASB issued ASU 2024-03, “Disaggregation of Income Statements Expenses (Subtopic 220-40),” to improve income statement expenses disclosure. The standard requires more detailed information related to the types of expenses, including (among other items) the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included within each interim and annual income statement’s expense caption, as applicable. This authoritative guidance can be applied prospectively or retrospectively and will be effective for financial statements issued for annual periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently in the process of evaluating the impact of adoption on its consolidated financial statements.

 

The Company believes there is no additional new accounting guidance adopted, but not yet effective, which is relevant to the readers of our financial statements. However, there are numerous new proposals under development which, if and when enacted, may have a significant impact on our financial reporting.

 

NOTE 4: CONCENTRATION OF CREDIT RISK

 

Cash and cash equivalents

 

The Company had cash and cash equivalents of $23.5 million and $8.7 million at June 30, 2026 and December 31, 2025, respectively. The Company invests excess cash in U.S. treasury securities, certificates of deposit or deposit accounts, all with maturities of less than three months. Cash equivalents consisting of U.S. treasury securities were $23.3 million and $8.2 million at June 30, 2026 and December 31, 2025, respectively.

 

The Company’s cash balances are held in United States financial institutions, which from time to time may exceed the Federal Deposit Insurance Corporation limit. There were no amounts at risk at June 30, 2026 and December 31, 2025.

 

Accounts receivable

 

The Company routinely assesses the financial strength of its customers. In accordance with the “expected credit loss” model of ASC 326, the carrying amount of accounts receivable is reduced by a valuation allowance that reflects the best estimate of the amounts the Company does not expect to collect. In addition to reviewing delinquent accounts receivable, the Company considers many factors in estimating our reserve, including types of customers and their credit worthiness, experience and historical data adjusted for current conditions and reasonable supportable forecasts. The Company records an allowance for credit losses based upon a specific review of all significant outstanding invoices. For those invoices not specifically reviewed, provisions are provided based upon the collection history, current economic trends and reasonable supportable forecasts.

 

Accounts receivable is presented net of an allowance for credit losses of $15,000 and $30,000 as of June 30, 2026 and December 31, 2025, respectively. The allowance is based on prior experience and management’s evaluation of future economic conditions. Measurement of credit losses requires consideration of historical loss experience, including the need to adjust for changing business conditions, and judgments about the probable effects of relevant observable data, including present economic conditions such as delinquency rates and the financial health of specific customers. Future changes to the estimated allowance for credit losses could be material to our results of operations and financial condition.

 

12

 

 

NOTE 4: CONCENTRATION OF CREDIT RISK (continued)

 

At June 30, 2026, the accounts receivable balance included amounts from two customers that represented 53.2% and 27.3% of total accounts receivable. As of December 31, 2025, the accounts receivable balance includes amounts from two customers that represented 57.0% and 28.2% of total accounts receivable.

 

Sales concentration

 

Revenue from a single customer in any one period can exceed 10% of our total revenues. During the three months ended June 30, 2026, two customers represented 50.9% and 24.3% of revenues, and during the six months ended June 30, 2026, three customers represented 39.4%, 20.9%, and 14.3% of revenues.

 

During the three months ended June 30, 2025, three customers represented 34.9%, 21.0% and 11.8% of revenues, and during the six months ended June 30, 2025, three customers represented 47.3%, 21.3% and 10.9% of revenues.

 

NOTE 5: REVENUE RECOGNITION

 

The following table represents a disaggregation of revenue for the three and six months ended June 30, 2026, and 2025 (in thousands):

  

   Over time   Point in time   Total 
   Three months ended June 30, 2026 
   Over time   Point in time   Total 
             
Energy  $-   $-   $- 
Aerospace   351    804    1,155 
Industrial   475    210    685 
Research   94    19    113 
Total  $920   $1,033   $1,953 

 

   Over time   Point in time   Total 
   Three months ended June 30, 2025 
   Over time   Point in time   Total 
             
Energy  $(4)  $11   $7 
Aerospace   1,371    560    1,931 
Industrial   1,197    46    1,243 
Research   174    49    223 
Total  $2,738   $666   $3,404 

 

   Over time   Point in time   Total 
   Six months ended June 30, 2026 
   Over time   Point in time   Total 
             
Energy  $-   $-   $- 
Aerospace   752    1,503    2,255 
Industrial   796    299    1,095 
Research   348    100    448 
Total  $1,896   $1,902   $3,798 

 

13

 

 

NOTE 5: REVENUE RECOGNITION (continued)

 

   Over time   Point in time   Total 
   Six months ended June 30, 2025 
   Over time   Point in time   Total 
             
Energy  $(4)  $19   $15 
Aerospace   3,093    1,343    4,436 
Industrial   4,616    327    4,943 
Research   200    143    343 
Total  $7,905   $1,832   $9,737 

 

The energy market includes customers involved in the manufacture of silicon carbide wafers and batteries. The aerospace market includes customers that manufacture aircraft engines. The industrial end market consists of various end customers in diverse industries. The research market principally represents customers such as universities and other research institutions.

 

The Company has unrecognized contract revenue of approximately $2.7 million at June 30, 2026 which it expects to substantially recognize as revenue within the next twelve months based on over time revenue recognition.

 

Judgment is required to evaluate assumptions including the amount of net contract revenues and the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize.

 

Changes in estimates for sales of systems may occur for a variety of reasons, including but not limited to (i) build accelerations or delays, (ii) product cost forecast changes, (iii) cost related change orders or add-ons, or (iv) changes in other information used to estimate costs. Changes in estimates may have a material effect on the Company’s condensed consolidated statements of operations.

 

Contract assets and liabilities

 

Contract assets and contract liabilities on input method type contracts in progress are summarized as follows as of June 30, 2026 (in thousands):

 

      
Costs incurred on contracts in progress  $20,582 
Estimated earnings   9,254 
Costs and estimated earnings on uncompleted contracts   29,836 
Billings to date   (28,632)
Net cost in excess of billings   1,204 
      
Deferred revenue related to non-system contracts   (348)
Contract liability in excess of contract assets  $856 
Included in accompanying condensed consolidated balance sheet as of June 30, 2026 under the following captions:     
Contract assets  $1,397 
Contract liabilities  $541 

 

Of the contract liability balances at December 31, 2025 and 2024, $0.3 million and $2.1 million was recognized as revenue during the six months ended June 30, 2026 and 2025, respectively. Contract assets and contract liabilities at December 31, 2024 were $2.1 million and $3.0 million, respectively.

 

14

 

 

NOTE 6: INVENTORIES

 

Inventories consist of:

 

   June 30, 2026   December 31, 2025 
         
Raw materials  $89   $          137 
Work-in-process   158    148 
Finished goods   -    - 
Total  $247   $285 

 

NOTE 7: LONG-TERM DEBT

 

In September 2022, the Company entered into a loan agreement to fund the acquisition of machinery. The loan amount of $432,000 was payable in 60 equal monthly installments of $8,352 and secured by equipment. The interest rate was 6%. This loan was fully repaid during the three months ended March 31, 2026.

 

NOTE 8: EARNINGS PER SHARE

 

The calculation of basic and diluted weighted average common shares outstanding for the three and six months ended June 30, 2026 and 2025 is as follows:

 

   2026   2025   2026   2025 
   Three months ended June 30,   Six months ended June 30, 
   2026   2025   2026   2025 
                 
Basic weighted average common shares outstanding   6,927,388    6,867,868    6,918,614    6,860,846 
Dilutive effect of options and unvested restricted stock   -    -    -    - 
Diluted weighted average shares outstanding   6,927,388    6,867,868    6,918,614    6,860,846 

 

For the three and six months ended June 30, 2026 and 2025, all stock options were excluded in the computation of diluted earnings per share because their effect was antidilutive.

 

NOTE 9: STOCK-BASED COMPENSATION EXPENSE

 

The Company recorded stock-based compensation for the three and six months ended June 30, 2026 and 2025, respectively, that were included in the following line items in our condensed consolidated statements of operations (in thousands):

 

   2026   2025   2026   2025 
   Three months ended June 30,   Six months ended June 30, 
   2026   2025   2026   2025 
                 
Cost of revenue  $23   $26   $45   $53 
Research and development   33    45    71    92 
Selling   13    21    27    47 
General and administrative   133    145    266    295 
                     
Total  $202   $237   $409   $487 

 

15

 

 

NOTE 9: STOCK-BASED COMPENSATION EXPENSE (continued)

 

Stock-based compensation related to discontinued operations were $0 and $13,000 for the three months ended June 30, 2026 and 2025, respectively, and $13,000 and $27,000 for the six months ended June 30, 2026 and 2025, respectively. Stock-based compensation expense for three months ended June 30, 2026 and 2025 included $50,000 and $50,000, respectively, and for the six month periods June 30, 2026 and 2025 included $100,000 and $100,000, respectively, related to restricted stock awards that directors are entitled to receive pursuant to the Director Compensation Plan. Under this plan each of the Company’s independent directors is entitled to an Annual Equity Retainer in the amount of $40,000, to be granted on the date of the Company’s annual meeting of shareholders.

 

The following table summarizes stock options awards through June 30, 2026:

 

       Weighted 
   Stock Option   Average 
   Awards   Exercise 
   (in shares)   Price 
         
Outstanding at January 1, 2026   803,875   $        8.17 
Exercised   (31,875)   4.41 
Forfeited   (19,750)   7.64 
Outstanding at June 30, 2026   752,250    8.35 

 

The following table summarizes information about the outstanding and exercisable options at June 30, 2026 by ranges of exercise prices:

 

     Options Outstanding   Options Exercisable 
        Weighted   Weighted           Weighted     
Exercise       Average   Average           Average     
Price   Number   Remaining   Exercise   Intrinsic   Number   Exercise   Intrinsic 
Range   Outstanding   Contractual   Price   Value   Exercisable   Price   Value 
$ 4.00-7.00    395,500    5.4   $4.55   $1,216,200    354,125   $4.49   $1,158,099 
$ 7.01-10.00    20,000    1.8   $8.07   $-    20,000   $8.07   $- 
$ 10.01-13.00    120,000    0.7   $10.52   $-    120,000   $10.52   $- 
$ 13.01-16.00    216,750    6.7   $14.11   $-    165,375   $14.11   $- 

 

As of June 30, 2026, there was $0.4 million of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 0.7 years.

 

NOTE 10: INCOME TAXES

 

For the three and six months ended June 30, 2026, the Company recorded income tax expense of $0.7 million that was related to the gain on the divestiture of SDC. As of June 30, 2026 and December 31, 2025, the Company has provided a full valuation allowance against its net deferred tax asset. This was based on management’s assessment, including the last four years of operating losses, that it is more likely than not that the net deferred tax asset may not be realized in the future. Management continues to evaluate for potential utilization of the Company’s net deferred tax asset, which has been fully reserved for, on a quarterly basis, reviewing our economic models, including projections of future operating results.

 

16

 

 

NOTE 11: SEGMENT REPORTING

 

With the sale of the Company’s SDC business in 2026 and the cessation of its MesoScribe business in 2024, the Company has one reportable segment consisting of its CVD Equipment division that manufactures chemical vapor deposition, physical vapor transport, thermal process and related equipment.

 

The chief operating decision maker (“CODM”) of the Company is the Company’s chief executive officer. The CODM assesses performance and decides how to allocate resources, including employees, financial or capital resources, based on segment net income (loss).

 

The following table presents revenue by geographic area (in thousands):

 

   2026   2025 
   Three months ended
June 30,
 
   2026   2025 
United States  $1,903   $3,129 
North America, excluding US   -    - 
Europe, Middle East and Africa   50    248 
Asia-Pacific   -    27 
Consolidated total revenue  $1,953   $3,404 

 

   2026   2025 
   Six months ended
June 30,
 
   2026   2025 
United States  $3,586   $9,178 
North America, excluding US   1    3 
Europe, Middle East and Africa   211    419 
Asia-Pacific   -    137 
Consolidated total revenue  $3,798   $9,737 

 

For geographical reporting, revenues are attributed to the location in which the customer facility is located. All the Company’s long-lived assets are located in the United States.

 

NOTE 12: RISKS AND CONTINGENCIES

 

The Company operates in a challenging and uncertain global economic environment. Recent and potential actions by the U.S. federal administration, including changes in trade policy, export controls, and tariffs on imports from various countries and regions, as well as retaliatory or responsive actions by other governments, may adversely affect the Company’s supply chain, costs, demand for its products, receipt of orders and results of operations. In addition, the Company faces ongoing risks related to geopolitical instability, including conflicts and tensions in Europe, the Middle East, and Asia, which may further disrupt global economic conditions and financial markets.

 

Other factors contributing to economic uncertainty include inflationary pressures, elevated interest rates, disruptions in global logistics, labor market challenges, and potential changes in fiscal, tax, or regulatory policies. These conditions may impact customer spending decisions, order rates, project timing, and the availability and cost of materials and components used in the Company’s products.

 

While management continuously evaluates these conditions and has taken, and may take, actions intended to mitigate the potential adverse effects on the Company’s business, there can be no assurance that such actions will be successful. The Company is unable to predict the ultimate impact of these risks and uncertainties on its future results of operations, financial position, or cash flows.

 

17

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Except for historical information contained herein, this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contains forward–looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. These statements involve known and unknown risks and uncertainties that may cause our actual results or outcomes to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on various factors and are derived utilizing numerous important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements. Important assumptions and other factors that could cause actual results to differ materially from those in the forward-looking statements, include, but are not limited to:

 

  uncertainty as to the receipt of and timing of future orders for our equipment;
     
  uncertainty as to the acceptance of our equipment launched in 2024 and 2025;
     
  uncertainty as to the general state of the silicon carbide wafer end market;
     
  competition in our existing and potential future product lines of business, including our aerospace equipment and PVT systems;
     
  uncertainty as to our ability to identify and develop new products for growth markets;
     
  our ability to obtain financing on acceptable terms if and when needed;
     
  our ability to attract and retain key personnel and employees;
     
  uncertainty as to changes to international trade policies including the imposition of tariffs; and
     
  uncertainty as to our ability to adequately obtain raw materials and on commercially reasonable terms.

 

Other factors and assumptions not identified above were also involved in the derivation of these forward-looking statements and the failure of such assumptions to be realized as well as other factors may also cause actual results to differ materially from those projected. We assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking statements. Past performance is no guaranty of future results.

 

You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made. When used with this Report, the words “believes” “anticipates”, “expects”, “estimates”, “plans”, “intends”, “will” and similar expressions are intended to identify forward-looking statements.

 

Executive Summary

 

CVD has served the advanced materials markets with chemical vapor deposition, physical vapor transport and thermal process equipment for over 40 years. We are headquartered in Central Islip, New York.

 

On November 6, 2025, our Board of Directors approved a comprehensive strategy to transform our Company in response to the continued fluctuations in our order rates and the recent and continued decline in the bookings of our CVD Equipment division. As part of this strategy, we transitioned our operating model for our CVD Equipment business from vertically integrated fabrication to outsourced fabrication of certain components to reduce our fixed operating costs.

 

18

 

 

The transformation strategy also includes the exploration of strategic alternatives for remaining business and product lines, including the potential sale, divestiture or acquisition of assets or business lines.

 

On March 23, 2026, we entered into an asset purchase agreement with a third party to sell our SDC business division (“SDC”). The purchase price was approximately $17.4 million in cash, subject to customary purchase price adjustments. The transaction closed on April 1, 2026.

 

The net cash proceeds from the sale of SDC we received in April 2026, after payment of transaction costs and employee related liabilities, were $15.7 million. The Company expects to pay approximately $0.7 million in estimated income taxes related to the gain on the sale of SDC in the third quarter of 2026. Following the sale of SDC, the Company has $23.5 million in cash and no long-term debt as of June 30, 2026. We expect to use the proceeds from the transaction to enhance our financial flexibility as we continue to evaluate strategic opportunities for the CVD Equipment business, its product lines, and our facilities and possible acquisition of other product lines or businesses

 

We retained ownership of our Saugerties, New York facility following the sale of SDC, which is leased to the acquiring company for an initial term of two years at fair market value.

 

With the sale of our SDC business and the cessation of our MesoScribe business in 2024, we have one reportable segment consisting of our CVD Equipment division that manufactures chemical vapor deposition, physical vapor transport and thermal process equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, battery energy storage markets as well as advanced industrial applications, and research.

 

During the quarter ended June 30, 2026 (from continuing operations):

 

  Revenue decreased by $1.4 million or 42.6% as compared to the second quarter of 2025 from lower systems revenue due to reduced system bookings.
     
  Gross profit decreased by $0.2 million or 31.6% as compared to the second quarter of 2025 due to the lower system revenues.
     
  Total bookings for the second quarter of 2026 were approximately $1.2 million as compared to bookings of $1.5 million in the second quarter of 2025. Bookings for the second quarter of 2026 included one system order for $0.8 million with the balance consisting of non-system orders.
     
  Total bookings for the first half of 2026 were approximately $2.9 million as compared to bookings of $2.3 million in the first half of 2025.
     
  Backlog declined from $4.6 million at March 31, 2026 to $3.9 million at June 30, 2026 due to lower system orders.
     
  Cash and cash equivalents at June 30, 2026 were $23.5 million as compared to $8.7 million at December 31, 2025 as a result of the receipt of proceeds from the divestiture of SDC in April 2026.

 

Subsequent to quarter-end, the customer that placed the approximately $0.8 million system order filed a prepackaged Chapter 11 bankruptcy proceeding. The customer’s public disclosures indicate that general unsecured trade creditors are expected to be unimpaired under the proposed plan of reorganization; however, there can be no assurance that the customer will proceed with the purchase as originally contemplated or that the bankruptcy process will not adversely affect the order. The Company will be monitoring the proceedings and evaluating the potential impact, if any, on its backlog, financial position, results of operations, and cash flows.

 

Business Update

 

As of December 31, 2025, we classified certain manufacturing equipment as held for sale with a fair value of $0.5 million based on an agreement we entered into in January 2026 with a third-party to sell the equipment for this amount. We received the proceeds from the sale in the first quarter of 2026 and also sold additional equipment for $46,000 that was no longer necessary for our business.

 

Our core strategy remains focused on serving key markets related to aerospace, microelectronics/power electronics and industrial applications.

 

19

 

 

With respect to aerospace, our systems are being used by our customers to produce ceramic matrix composite materials (“CMCs”) that will be used in next generation gas turbine jet engines with the objective of reducing jet fuel consumption and to produce specialty coatings for advanced high temperature environments.

 

In October 2025, we sold two PVT150™ units to Stony Brook University (SBU) for their new semiconductor research center - onsemi Silicon Carbide Crystal Growth Center. The recently launched research center will enable SBU faculty, scientists, and students to conduct research on silicon carbide crystal growth and other wide band gap (WBG) materials and device-enabling technologies critical to improving energy efficiency in power semiconductors and foster the next generation of skilled professionals in this field.

 

We have generally gained new customers through our industry reputation, as well as trade show attendance, digital marketing and print advertising. We have increased the number of trade shows and industry conferences we attend.

 

We continue to operate in a challenging and uncertain global economic environment. Recent and potential actions by the U.S. federal administration, including changes in trade policy, export controls, and tariffs on imports from various countries and regions, as well as retaliatory or responsive actions by other governments, may adversely affect our supply chain, costs, demand for our products, receipt of orders and results of operations. In addition, we face ongoing risks related to geopolitical instability, including conflicts and tensions in Europe, the Middle East, and Asia, which may further disrupt global economic conditions and financial markets.

 

Other factors contributing to economic uncertainty include inflationary pressures, elevated interest rates, disruptions in global logistics, labor market challenges, and potential changes in fiscal, tax, or regulatory policies. These conditions may impact customer spending decisions, order rates, project timing, and the availability and cost of materials and components used in our products.

 

While our management continuously evaluates these conditions and has taken, and may take, actions intended to mitigate the potential adverse effects on our business, there can be no assurance that such actions will be successful. We are unable to predict the ultimate impact of these risks and uncertainties on our future results of our operations, financial position, or cash flows.

 

20

 

 

Results of Operations

 

Three Months Ended June 30, 2026 and 2025

 

The following table presents revenue and expense line items reported in our condensed consolidated statements of operations for the three months ended June 30, 2026 and 2025 and the period-over-period dollar and percentage changes for those line items (in thousands, except percentages).

 

   Three months ended June 30     
   2026   2025   Change   Percent 
Revenue  $1,953   $3,404   $(1,451)   (42.6)%
Cost of revenue   1,624    2,923    (1,299)   (44.4)%
                     
Gross profit   329    481    (152)   (31.6)%
Gross margin   16.8%   14.1%          
                     
Operating expenses:                    
Research and development   685    639    46    7.2%
Selling   232    282    (50)   (17.7)%
General and administrative   971    931    40    4.3%
                     
Total operating expenses   1,888    1,852    36    1.9%
                     
Operating loss from continuing operations   (1,559)   (1,371)   (188)   13.7%
                     
Other income (expense):                    
Interest income   190    82    108    131.7%
Interest expense   -    (3)   3    *  
Rental income, net of expenses   (3)   -    (3)   *  
                     
Total other income, net   187    79    108    136.7%
                     
Loss from continuing operations before
income taxes
   (1,372)   (1,292)   (80)   6.2%
                     
Income tax expense   -    -    -    *  
                     
Net loss from continuing operations   (1,372)   (1,292)   (80)   6.2%
                     
Income from discontinued operations, net of income taxes   13,937    231    13,706    * 
                     
Net income (loss)  $12,565   $(1,061)  $13,626    * 

 

* Not meaningful

 

Revenue

 

Our revenue for the three months ended June 30, 2026 was $2.0 million compared to $3.4 million for the three months ended June 30, 2025, a decrease of $1.4 million or 42.6%.

 

21

 

 

The decrease in revenue versus the prior year period was primarily attributable to lower system revenue due to lower bookings being partially offset by an increase in non-system revenues. Revenue from two customers represented 50.9% and 24.3% of our revenues, respectively.

 

Our order backlog at June 30, 2026 was approximately $3.9 million as compared to $4.6 million at March 31, 2026. Our order backlog at June 30, 2026 consists of approximately $2.7 million related to remaining performance obligations of contracts in progress and the balance of approximately $1.1 million represents other orders received from customers. As of June 30, 2026, one aerospace customer represented 36.0% of our backlog.

 

Historically, our revenues and orders have fluctuated based on changes in order rate as well as other factors in our manufacturing process that impacts the timing of revenue recognition. Accordingly, orders received from customers and revenue recognized may fluctuate from quarter to quarter.

 

Gross Profit

 

Gross profit for the three months ended June 30, 2026 was $0.3 million, with a gross margin of 16.8%, compared to a gross profit of $0.5 million and a gross margin of 14.1% for the three months ended June 30, 2025. The decrease in gross profit of $0.2 million was principally due to lower system revenues partially offset by an increase in non-system revenues.

 

Research and Development

 

For the three months ended June 30, 2026, research and development expenses were $0.7 million, or 35.1% of revenue as compared to $0.6 million, or 18.8% of revenue for the three months ended June 30, 2025, an increase of $46,000 or 7.2%. The increase in 2026 was the result of less hours being charged to cost of revenue for contracts in progress partially offset by a reduction in personnel.

 

General engineering support and expenses related to the development of more standardized products and value-added development of existing products are reflected as part of research and development expense. General engineering support and expenses are charged to costs of goods sold when work is performed directly on a customer order.

 

Selling

 

Selling expenses were $0.2 million or 11.9% of the revenue for the three months ended June 30, 2026 as compared to $0.3 million or 8.4% of revenue for the three months ended June 30, 2025, a decrease of $50,000 or 17.7%. The decrease was the result of a reduction in personnel.

 

General and Administrative

 

General and administrative expenses for the three months ended June 30, 2026 were $1.0 million or 49.7% of revenue compared to $0.9 million or 27.4% of revenue for the three months ended June 30, 2025, an increase of $40,000 or 4.3%. The increase in 2026 was due principally to higher professional fees.

 

Other Income (Expense), Net

 

Other income (expense) consists principally of interest income on U.S. treasury securities and increased as the result of investment of the proceeds from the divestiture of SDC.

 

Income Taxes

 

We continue to evaluate the potential utilization of our net deferred tax asset, which has been fully reserved for, on a quarterly basis, by reviewing our economic models, including projections of future operating results.

 

22

 

 

Discontinued Operations – SDC

 

Income from discontinued operations for the second quarter consists solely of the gain on the divestiture of the SDC of $13.9 million, net of income tax expense of $0.7 million. We incurred $0.4 million of transaction costs in the first quarter of 2026 resulting in a total net gain of $13.5 million on the divestiture of SDC.

 

Six Months Ended June 30, 2026 versus June 30, 2025

 

The following table presents revenue and expense line items reported in our condensed consolidated statements of operations for the six months ended June 30, 2025 and 2024 and the period-over-period dollar and percentage changes for those line items (in thousands, except percentages).

 

   Six months ended June 30     
   2026   2025   Change   Percent 
Revenue  $3,798   $9,737   $(5,939)   (61.0)%
Cost of revenue   3,321    7,451    (4,130)   (55.4)%
                     
Gross profit   477    2,286    1,809    (79.1)%
Gross margin   12.6%   23.5%          
                     
Operating expenses:                    
Research and development   1,413    1,373    40    2.9%
Selling   472    649    (177)   (27.3)%
General and administrative   1,992    1,954    38    1.9%
Gain on sale of equipment   (46)   -    (46)   * 
                     
Total operating expenses   3,831    3,976    (145)   (3.6)%
                     
Operating loss from continuing operations   (3,354)   (1,690)   (1,664)   98.5%
                     
Other income (expense):                    
Interest income   261    192    69    35.9%
Interest expense   (1)   (7)   6    (85.7)%
Rental income, net of expenses   (3)   -    (3)   *  
Total other income, net   257    185    72    38.9%
                     
Loss from continuing operations before
income taxes
   (3,097)   (1,505)   (1,592)   105.8%
                     
Income tax expense   -    16    (16)   * 
                     
Net loss from continuing operations   (3,097)   (1,521)   (1,576)   103.6%
                     
Income from discontinued operations, net of income taxes   13,999    820    13,179    * 
                     
Net income (loss)  $10,902   $(701)  $11,603    * 

 

* Not meaningful

 

23

 

 

Revenue

 

Our revenue for the six months ended June 30, 2026 was $3.8 million compared to $9.7 million for the six months ended June 30, 2025, a decrease of $5.9 million or 61.0%. The decrease was partially offset by $0.3 million benefit from a contract modification during the six months ended June 30, 2026.

 

The decrease in revenue versus the prior year period was primarily attributable to lower system revenue due to lower bookings. Revenue from three customers represented 39.4%, 20.9% and 14.3% of our revenues, respectively.

 

Gross Profit

 

Gross profit for the six months ended June 30, 2026 was $0.5 million, with a gross margin of 12.6%, compared to a gross profit of $2.3 million and a gross margin of 23.5% for the six months ended June 30, 2025. The decrease in gross profit of $1.8 million was principally due to lower system revenues.

 

Research and Development

 

For the six months ended June 30, 2026, research and development expenses were $1.4 million, or 37.2% of revenue as compared to $1.4 million, or 14.1% of revenue for the six months ended June 30, 2025, an increase of $40,000 or 2.9%. The increase in 2026 was the result of less hours being charged to cost of revenue for contracts in progress being partially offset by a reduction in personnel.

 

General engineering support and expenses related to the development of more standardized products and value-added development of existing products are reflected as part of research and development expense. General engineering support and expenses are charged to costs of goods sold when work is performed directly on a customer order.

 

Selling

 

Selling expenses were $0.5 million or 12.4% of the revenue for the six months ended June 30, 2026 as compared to $0.6 million or 6.7% of revenue for the six months ended June 30, 2025, a decrease of $0.2 million or 27.3%. The decrease was the result of a reduction in personnel.

 

General and Administrative

 

General and administrative expenses for the six months ended June 30, 2026 were $2.0 million or 52.4% of revenue compared to $2.0 million or 20.1% of revenue for the six months ended June 30, 2025, an increase of $38,000 or 1.9%. The increase was principally due to higher professional fees.

 

Gain on Sales of Equipment

 

We recognized a gain of $46,000 on the sale of equipment that was no longer necessary for our business during the first quarter of 2026.

 

Other Income (Expense), Net

 

Other income (expense) consists principally of interest income on U.S. treasury securities and increased as the result of investment of the proceeds from the divestiture of SDC.

 

Income Taxes

 

We continue to evaluate the potential utilization of our deferred tax asset, which has been fully reserved for, on a quarterly basis, by reviewing our economic models, including projections of future operating results.

 

24

 

 

Discontinued Operations – SDC

 

Income from discontinued operations consists of $0.5 million from the operations of SDC during the first quarter of 2026 and the gain on the sale of the divestiture of SDC of $13.5 million. The gain is net of related income tax expense of $0.7 million.

 

Liquidity and Capital Resources

 

As of June 30, 2026, aggregate working capital was $25.8 million as compared to aggregate working capital of $14.1 million at December 31, 2025. Cash and cash equivalents at June 30, 2026 and December 31, 2025 were $23.5 million and $8.7 million, respectively.

 

Net cash used in operating activities for the six months ended June 30, 2026 was $1.3 million. This use of net cash was principally due to the net loss from continuing operations of $3.1 million, a $0.9 million increase in accounts receivable and a $0.3 million reduction in accounts payable. These decreases were partially offset by non-cash expense items of $0.7 million, decrease in contract assets of $1.7 million, and a decrease in inventory of $0.4 million.

 

Net cash provided by investing activities for the six months ended June 30, 2026 principally consisted of net proceeds from the divestiture of SDC of $15.6 million and proceeds from the sale of assets held for sale and equipment of $0.6 million. The Company expects to pay approximately $0.7 million in estimated income taxes related to the gain on the sale of SDC in the third quarter of 2026.

 

Net cash used in financing activities for the six months ended June 30, 2026 consisted of the full repayment of an equipment loan in the amount of $181,000. As of June 30, 2026, we have no outstanding debt.

 

We believe that our cash and cash equivalent positions and our projected cash flow from operations will be sufficient to meet our working capital and capital expenditure requirements for the next twelve months from the filing of these financial condensed consolidated financial statements included in this Form 10-Q. We will continue to assess our operations and take actions anticipated to maintain our operating cash to support the working capital needs.

 

Critical Accounting Estimates

 

This discussion and analysis of the Company’s financial condition and results of operations is based on the Company’s consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods.

 

In accordance with U.S. GAAP, we base our estimates on historical experience and on various other assumptions the Company believes are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

We consider the following estimates within our significant accounting policies to be critical because of their complexity and the high degree of judgment involved in maintaining them. See Note 3 – “Summary of Significant Accounting Policies” of our Consolidated Financial Statements for additional information regarding our accounting policies.

 

25

 

 

Revenue Recognition

 

We design, manufacture, and sell custom chemical vapor deposition equipment through contractual agreements. These system sales require us to deliver functioning equipment that is generally completed within two to eighteen months from commencement of order acceptance. We recognize revenue over time by using an input method based on costs incurred as it depicts our progress toward satisfaction of the performance obligation. Under this method, revenue arising from fixed price contracts is recognized as work is performed based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligations.

 

Incurred costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs. Contract material costs are included in incurred costs when the project materials have been purchased or moved to work-in-process as required by the project’s engineering design. Cost based input methods of revenue recognition require us to make estimates of costs to complete the projects. In making such estimates, significant judgment is required to evaluate assumptions related to the costs to complete the projects, including materials, labor, and other system costs. If the estimated total costs on any contract are greater than the net contract revenues, we recognize the entire estimated loss in the period the loss becomes known and can be reasonably estimated.

 

We have been engaged in the production and delivery of goods on a continual basis under contractual arrangements for many years. Historically, we have demonstrated an ability to accurately estimate total revenues and total expenses relating to our long-term contracts. However, there exist many inherent risks and uncertainties in estimating revenues, expenses, and progress toward completion, particularly on larger or longer-term contracts. If we do not estimate the total sales, related costs, and progress toward completion on such contracts, the estimated gross margins may be significantly impacted, or losses may need to be recognized in future periods. Any such resulting changes in margins or contract losses could be material to our results of operations and financial condition.

 

Long-Lived Assets

 

Long-lived assets consist primarily of property, plant and equipment. Long-lived assets are reviewed for impairment whenever events or circumstances indicate their carrying value may not be recoverable. When such events or circumstances arise, an estimate of the future undiscounted cash flows produced by the asset, or the appropriate grouping of assets, is compared to the asset’s carrying value to determine if impairment exists pursuant to the requirements of ASC 360-10-35, “Impairment or Disposal of Long-Lived Assets.” If the asset is determined to be impaired, the impairment loss is measured on the excess of it carrying value over its fair value. Assets to be disposed of are reported at the lower of their carrying value or net realizable value. Assets to be disposed of are reported at the lower of their carrying value or net realizable value. It is not possible for us to predict the likelihood of any possible future impairments or, if such an impairment were to occur, the magnitude of any impairment.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended, (the “Exchange Act”)). As required by Rule 13a-15(b) under the Exchange Act, our management, under the direction of our Chief Executive Officer and Chief Financial Officer, reviewed and performed an evaluation of the effectiveness of design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Report”).

 

Based on that review and evaluation, our Chief Executive Officer and Chief Financial Officer, along with others in our management, have determined that as of the end of the period covered by this Report on Form 10-Q the disclosure controls and procedures were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive and financial officers, as appropriate to allow timely decisions regarding disclosures.

 

Changes in Internal Controls

 

There were no changes in our internal controls over financial reporting as defined in Rule 13a-15(f) or Rule 15d-15(f) under the Exchange Act that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the internal controls over financial reporting.

 

Limitations on the Effectiveness of Controls

 

We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

 

26

 

 

CVD EQUIPMENT CORPORATION

 

PART II

 

OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors.

 

There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K as filed with the Securities and Exchange Commission on March 30, 2026.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

Item 6.   Exhibits
     
31.1*   Certification of Emmanuel Lakios, Chief Executive Officer, dated August 12, 2026
     
31.2*   Certification of Richard Catalano, Chief Financial Officer, dated August 12, 2026
     
32.1*   Certification of Emmanuel Lakios, Chief Executive Officer, dated August 12, 2026, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2*   Certification of Richard Catalano, Chief Financial Officer, dated August 12, 2026, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.1**   Inline XBRL Instance.
     
101.SCH**   Inline XBRL Taxonomy Extension Schema.
     
101.CAL**   Inline XBRL Taxonomy Extension Calculation.
     
101.DEF**   Inline XBRL Taxonomy Extension Definition.
     
101.LAB**   Inline XBRL Taxonomy Extension Labels.
     
101.PRE**   Inline XBRL Taxonomy Extension Presentation.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith.

 

** Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not to be filed or part of a registration statement of prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

 

27

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, this 12th day of August 2026.

 

  CVD EQUIPMENT CORPORATION
     
  By:  /s/ Emmanuel Lakios
    Emmanuel Lakios
    President and Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Richard Catalano
    Richard Catalano
    Executive Vice President and
    Chief Financial Officer
   

(Principal Financial and Accounting Officer)

 

28